Online Cognitive and Behavioural Therapy for Insomnia in Australian General Practice: An Implementation Trial

The Adelaide Institute for Sleep Health, Flinders University0 sites375 target enrollmentNovember 7, 2019

Overview

No summary available.

Registry

who.int

Start Date

November 7, 2019

End Date

TBD

Last Updated

5 years ago

Study Type

Interventional

Sex

All

Sponsor

The Adelaide Institute for Sleep Health, Flinders University

•General Practitioner Inclusion Criteria;
•1\. Currently using the Doctors Control Panel software
•Patient Inclusion Criteria
•1\. Age \> 18 years.
•2\. Reliable access to computer, tablet or smartphone, with internet access
•3\. Basic English language comprehension as required for Sleepio.
•Group 1 New Insomnia \- No GP prescriptions of Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone, or Melatonin in the past 12 months,
•Group 2 Single Sleeping Pill Prescription \- One GP prescription of Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone, or Melatonin in the past 12 months,
•Group 3 Repeat Sleeping Pill Prescriptions \- Any combination of two or more GP prescriptions of Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone, or Melatonin in the past 12 months.

•Patient Exclusion Criteria (assessed by treating GPs, according to RACGP/Sleepio recommendations);
•1\. Drug or alcohol problems
•2\. Terminal illness
•3\. Acute crisis
•4\. Risk of suicide
•5\. Severe mental illness
•6\. Organic brain disease
•7\. Epilepsy requiring benzodiazepine as part of anticonvulsant therapy
•8\. Benzodiazepine prescriptions for muscle spasms
•9\. Women who are currently pregnant